181 related articles for article (PubMed ID: 33429882)
1. Antipseudomonal and Immunomodulatory Properties of Esc Peptides: Promising Features for Treatment of Chronic Infectious Diseases and Inflammation.
Cappiello F; Carnicelli V; Casciaro B; Mangoni ML
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33429882
[TBL] [Abstract][Full Text] [Related]
2. Esculentin-1a-Derived Peptides Promote Clearance of Pseudomonas aeruginosa Internalized in Bronchial Cells of Cystic Fibrosis Patients and Lung Cell Migration: Biochemical Properties and a Plausible Mode of Action.
Cappiello F; Di Grazia A; Segev-Zarko LA; Scali S; Ferrera L; Galietta L; Pini A; Shai Y; Di YP; Mangoni ML
Antimicrob Agents Chemother; 2016 Dec; 60(12):7252-7262. PubMed ID: 27671059
[TBL] [Abstract][Full Text] [Related]
3. An Overview of Frog Skin-Derived Esc Peptides: Promising Multifunctional Weapons against
Mangoni ML; Loffredo MR; Casciaro B; Ferrera L; Cappiello F
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673985
[TBL] [Abstract][Full Text] [Related]
4. Bronchial epithelium repair by Esculentin-1a-derived antimicrobial peptides: involvement of metalloproteinase-9 and interleukin-8, and evaluation of peptides' immunogenicity.
Cappiello F; Ranieri D; Carnicelli V; Casciaro B; Chen HT; Ferrera L; Di YP; Mangoni ML
Sci Rep; 2019 Dec; 9(1):18988. PubMed ID: 31831857
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of Rhesus Theta-Defensin-1 in Experimental Models of Pseudomonas aeruginosa Lung Infection and Inflammation.
Bensman TJ; Jayne JG; Sun M; Kimura E; Meinert J; Wang JC; Schaal JB; Tran D; Rao AP; Akbari O; Selsted ME; Beringer PM
Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28559270
[TBL] [Abstract][Full Text] [Related]
6. Persistent cystic fibrosis isolate Pseudomonas aeruginosa strain RP73 exhibits an under-acylated LPS structure responsible of its low inflammatory activity.
Di Lorenzo F; Silipo A; Bianconi I; Lore' NI; Scamporrino A; Sturiale L; Garozzo D; Lanzetta R; Parrilli M; Bragonzi A; Molinaro A
Mol Immunol; 2015 Feb; 63(2):166-75. PubMed ID: 24856407
[TBL] [Abstract][Full Text] [Related]
7. Membrane perturbing activities and structural properties of the frog-skin derived peptide Esculentin-1a(1-21)NH
Loffredo MR; Ghosh A; Harmouche N; Casciaro B; Luca V; Bortolotti A; Cappiello F; Stella L; Bhunia A; Bechinger B; Mangoni ML
Biochim Biophys Acta Biomembr; 2017 Dec; 1859(12):2327-2339. PubMed ID: 28912103
[TBL] [Abstract][Full Text] [Related]
8. Esculentin-1a Derived Antipseudomonal Peptides: Limited Induction of Resistance and Synergy with Aztreonam.
Casciaro B; Loffredo MR; Luca V; Verrusio W; Cacciafesta M; Mangoni ML
Protein Pept Lett; 2018; 25(12):1155-1162. PubMed ID: 30381056
[TBL] [Abstract][Full Text] [Related]
9. In vivo therapeutic efficacy of frog skin-derived peptides against Pseudomonas aeruginosa-induced pulmonary infection.
Chen C; Mangoni ML; Di YP
Sci Rep; 2017 Aug; 7(1):8548. PubMed ID: 28819175
[TBL] [Abstract][Full Text] [Related]
10. Antibacterial and anti-inflammatory activity of a temporin B peptide analogue on an in vitro model of cystic fibrosis.
Bezzerri V; Avitabile C; Dechecchi MC; Lampronti I; Borgatti M; Montagner G; Cabrini G; Gambari R; Romanelli A
J Pept Sci; 2014 Oct; 20(10):822-30. PubMed ID: 25201563
[TBL] [Abstract][Full Text] [Related]
11. The Impact of Lung Proteases on Snake-Derived Antimicrobial Peptides.
Creane SE; Carlile SR; Downey D; Weldon S; Dalton JP; Taggart CC
Biomolecules; 2021 Jul; 11(8):. PubMed ID: 34439773
[TBL] [Abstract][Full Text] [Related]
12. Lumacaftor (VX-809) restores the ability of CF macrophages to phagocytose and kill Pseudomonas aeruginosa.
Barnaby R; Koeppen K; Nymon A; Hampton TH; Berwin B; Ashare A; Stanton BA
Am J Physiol Lung Cell Mol Physiol; 2018 Mar; 314(3):L432-L438. PubMed ID: 29146575
[TBL] [Abstract][Full Text] [Related]
13. Activity of innate antimicrobial peptides and ivacaftor against clinical cystic fibrosis respiratory pathogens.
Payne JE; Dubois AV; Ingram RJ; Weldon S; Taggart CC; Elborn JS; Tunney MM
Int J Antimicrob Agents; 2017 Sep; 50(3):427-435. PubMed ID: 28666755
[TBL] [Abstract][Full Text] [Related]
14. Lipopolysaccharide (LPS), LPS-immune complexes and cytokines as inducers of pulmonary inflammation in patients with cystic fibrosis and chronic Pseudomonas aeruginosa lung infection.
Kronborg G
APMIS Suppl; 1995; 50():1-30. PubMed ID: 7756034
[TBL] [Abstract][Full Text] [Related]
15. Differential regulation of inflammation by inflammatory mediators in cystic fibrosis lung epithelial cells.
Tsuchiya M; Kumar P; Bhattacharyya S; Chattoraj S; Srivastava M; Pollard HB; Biswas R
J Interferon Cytokine Res; 2013 Mar; 33(3):121-9. PubMed ID: 23289731
[TBL] [Abstract][Full Text] [Related]
16. D-Amino acids incorporation in the frog skin-derived peptide esculentin-1a(1-21)NH2 is beneficial for its multiple functions.
Di Grazia A; Cappiello F; Cohen H; Casciaro B; Luca V; Pini A; Di YP; Shai Y; Mangoni ML
Amino Acids; 2015 Dec; 47(12):2505-19. PubMed ID: 26162435
[TBL] [Abstract][Full Text] [Related]
17. The treatment of respiratory pseudomonas infection in cystic fibrosis: what drug and which way?
Banerjee D; Stableforth D
Drugs; 2000 Nov; 60(5):1053-64. PubMed ID: 11129122
[TBL] [Abstract][Full Text] [Related]
18. Harnessing Neutrophil Survival Mechanisms during Chronic Infection by
Marteyn BS; Burgel PR; Meijer L; Witko-Sarsat V
Front Cell Infect Microbiol; 2017; 7():243. PubMed ID: 28713772
[TBL] [Abstract][Full Text] [Related]
19. TLR-induced inflammation in cystic fibrosis and non-cystic fibrosis airway epithelial cells.
Greene CM; Carroll TP; Smith SG; Taggart CC; Devaney J; Griffin S; O'neill SJ; McElvaney NG
J Immunol; 2005 Feb; 174(3):1638-46. PubMed ID: 15661927
[TBL] [Abstract][Full Text] [Related]
20. Novel Peptides with Dual Properties for Treating
Cappiello F; Verma S; Lin X; Moreno IY; Casciaro B; Dutta D; McDermott AM; Willcox M; Coulson-Thomas VJ; Mangoni ML
Biomolecules; 2023 Jun; 13(7):. PubMed ID: 37509064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
